Skip to main content
. 2011 Aug 26;6(8):e23016. doi: 10.1371/journal.pone.0023016

Figure 9. “Biological centrality” of the DS.

Figure 9

(A) Enrichment in BC and SP genes of the dominating set (“DS”) and its complement (“non-DS”) in the human PPI network. (B) Enrichment in drug targets of BC and SP genes that are in the dominating set (“DS”) and BC and SP genes that are not in the dominating set (“Non-DS”).